By Stephen D. Wiviott
* attracts from services of leaders in antiplatelet treatment* Easy-to-use structure allows speedy searching* Edited by way of a member of the distinguished TIMI examine workforce with long-standing event within the box
Read or Download Antiplatelet Therapy In Ischemic Heart Disease (American Heart Association Clinical Series) PDF
Similar cardiovascular books
Clinical Challenges in Hypertension II
This name offers an leading edge new method of healing decision-making and gives solutions to more than a few questions that the busy clinician faces each day. a chain of discussions, chosen by means of specialist individuals, all across the world known professionals of their fields, provide their very own suggestions for coping with tricky difficulties and provide insights into the price or differently of assorted therapy offerings in accordance with their very own event and the on hand proof.
Cardiovascular Magnetic Resonance: Established and Emerging Applications
An authoritative, updated source at the usually intimidating technical enigma of CMR, Cardiovascular Magnetic Resonance: validated and rising functions consolidates a large and transforming into physique of knowledge right into a unmarried balanced resource. This hugely illustrated textual content offers present and functional info on tested foundational functions of CMR.
Intracranial Hypertension (Neurology- Laboratory and Clinical Research Developments)
Intracranial high blood pressure (ICH) is the most typical reason behind scientific deterioration and dying for neurological and neurosurgical sufferers. there are lots of explanations of raised intracranial strain (ICP) and elevated ICP can produce intracranial high blood pressure syndromes. tracking of intracranial strain and advances in investigations of the critical frightened procedure have ended in new techniques and systemisations in intracranial high blood pressure.
Individual Differences in Cardiovascular Response to Stress
Demonstrating that the importance and trend of cardiovascular reaction to emphasize varies markedly among participants, this paintings discusses the mechanisms through which the cardiovascular procedure is mobilized in the course of tension, the determinants of person transformations, and the pathophysiological procedures during which responses to emphasize could lead to heart problems.
- Clinical gated cardiac SPECT
- Mayo Clinic Guide to Cardiac Magnetic Resonance Imaging
- Pathobiology of Cardiovascular Injury: From the proceedings of the Meeting of the American Section of the International Society for Heart Research (ISHR), Oklahoma City, Oklahoma September 13–15, 1984
- Hypertensive Cardiovascular Disease: Pathophysiology and Treatment
Extra resources for Antiplatelet Therapy In Ischemic Heart Disease (American Heart Association Clinical Series)
8 Weiss HJ. The discovery of the antiplatelet effect of aspirin: a personal reminiscence. J Thromb Haemost 2003; 1: 1869–1875. 9 Vane J. Towards a better aspirin. Nature 1994; 367: 215–216. 10 Picot D, Loll PJ, Garavito RM. The Xray crystal structure of the membrane protein prostaglandin H2 synthase 1. Nature 1994; 367: 243–249. 11 Loll PJ, Picot D, Garavito RM. The structural basis of ASA activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 1995; 2: 637–643.
Thromb Res 2003; 110: 265–268. 24 Bayer Health Care. Aspirin. html Accessed June 18, 2007. 25 Pedersen AK, Fitzgerald GA. Dose related kinetics of ASA: presystemic acetylation of platelet cyclooxygenase. New Eng J Med 1984; 311: 1206–1211. 26 MacPherson CR, Milne MD, Evans BM. The excretion of Salicylate. Br J Pharmacol 1955; 10: 484–489. 27 Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2006; 109: 2285–2292.
Aliment Pharm Therap 2006; 24: 896–908. 32 Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on ASA sensitivity and asthma. Curr Rev Allergy Clin Immunol 2006; 118: 773–786. 33 Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic FASEB J 2004; 18: 790–804. 34 Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase 2 by anti-inflammatory agents. Nature 1996; 384: 644–648. 35 Schaffer D, Florin T, Eagle C et al.